Jump to main content
Jump to site search

Issue 39, 2013
Previous Article Next Article

A multimodal, β-amyloid-targeted contrast agent

Author affiliations

Abstract

A multimodal, β-amyloid-targeted contrast agent was synthesized and studied in vitro. The agent has a higher relaxivity than a clinically approved contrast agent and interacts with β-amyloid aggregates producing changes in relaxation rate and fluorescence emission.

Graphical abstract: A multimodal, β-amyloid-targeted contrast agent

Back to tab navigation

Supplementary files

Publication details

The article was received on 11 Sep 2012, accepted on 18 Oct 2012 and first published on 09 Nov 2012


Article type: Communication
DOI: 10.1039/C2CC36583A
Citation: Chem. Commun., 2013,49, 4148-4150
  •   Request permissions

    A multimodal, β-amyloid-targeted contrast agent

    S. M. Vithanarachchi and M. J. Allen, Chem. Commun., 2013, 49, 4148
    DOI: 10.1039/C2CC36583A

Search articles by author

Spotlight

Advertisements